Koge Micro Tech Co., Ltd.

Research Koge Micro Tech Co., Ltd. (4568.TWO) on Bullrun: market cap TWD 1.33B, P/E 22.8, dividend yield 4.1%. Explore financials, valuation history, model signals, and stock context.

Key Metrics

Valuation Snapshot

latest market cap is TWD 1.33B; P/E is 22.8; dividend yield is 4.1%.

Peer valuation comparison

Latest P/E is 22.83x versus a Industrials sector median of 16.78x (36.0% above).

Latest dividend yield is 4.07% versus a Industrials sector median of 2.87% (41.8% above).

Valuation history

YearSnapshot dateMarket capP/EDividend yieldAnnual dividend/share
20262026-10-18TWD 1.33B22.84.8%1.98

Dividend history

Latest trailing dividend snapshot: annual dividend/share 1.98 TWD, yield 4.1%.

About Koge Micro Tech Co., Ltd.

Koge Micro Tech Co., Ltd. manufactures and sells air pumps, precision instruments, and medical equipment in Mainland China, Taiwan, the United States, and Vietnam. The company offers DC rotary diaphragm, DC diaphragm, linear air, piezoelectric, and brushless DC centrifugal pumps, as well as solenoid valve; and medical devices, such as negative pressure wound therapy, deep vein thrombosis, and PVA. It also acts as a contract development and manufacturing organization.

Related stock research

Other Industrials stocks

Frequently asked questions

What is Koge Micro Tech Co., Ltd.'s market cap?

Koge Micro Tech Co., Ltd.'s market capitalization is TWD 1.33B.

What is Koge Micro Tech Co., Ltd.'s P/E ratio?

Koge Micro Tech Co., Ltd.'s price-to-earnings (P/E) ratio is 22.8.

Does Koge Micro Tech Co., Ltd. pay a dividend?

Koge Micro Tech Co., Ltd. has a dividend yield of 4.1%.

What does Koge Micro Tech Co., Ltd. do?

Koge Micro Tech Co., Ltd. manufactures and sells air pumps, precision instruments, and medical equipment in Mainland China, Taiwan, the United States, and Vietnam. The company offers DC rotary diaphragm, DC diaphragm, linear air, piezoelectric, and brushless DC centrifugal pumps, as well as solenoid valve; and medical devices, such as negative pressure wound therapy, deep vein thrombosis, and PVA. It also acts as a contract development and manufacturing organization.